IL57436A0 - Hydantoin derivatives and pharmaceutical compositions containing them - Google Patents

Hydantoin derivatives and pharmaceutical compositions containing them

Info

Publication number
IL57436A0
IL57436A0 IL57436A IL5743679A IL57436A0 IL 57436 A0 IL57436 A0 IL 57436A0 IL 57436 A IL57436 A IL 57436A IL 5743679 A IL5743679 A IL 5743679A IL 57436 A0 IL57436 A0 IL 57436A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
hydantoin derivatives
hydantoin
derivatives
Prior art date
Application number
IL57436A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL57436A0 publication Critical patent/IL57436A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL57436A 1978-05-31 1979-05-30 Hydantoin derivatives and pharmaceutical compositions containing them IL57436A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25575/78A GB1599740A (en) 1978-05-31 1978-05-31 Hydantoin derivatives

Publications (1)

Publication Number Publication Date
IL57436A0 true IL57436A0 (en) 1979-09-30

Family

ID=10229898

Family Applications (1)

Application Number Title Priority Date Filing Date
IL57436A IL57436A0 (en) 1978-05-31 1979-05-30 Hydantoin derivatives and pharmaceutical compositions containing them

Country Status (11)

Country Link
JP (1) JPS554371A (sv)
AU (1) AU4762579A (sv)
BE (1) BE876670R (sv)
DE (1) DE2922070A1 (sv)
FR (1) FR2427331A2 (sv)
GB (1) GB1599740A (sv)
IL (1) IL57436A0 (sv)
IT (1) IT1164693B (sv)
NL (1) NL7904311A (sv)
SE (1) SE7904700L (sv)
ZA (1) ZA787354B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59065A0 (en) 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
GB2050371A (en) * 1979-05-09 1981-01-07 Wellcome Found Optically active hydantoin derivatives and pharmaceutical formulations containing them
EP0023083A1 (en) * 1979-06-27 1981-01-28 Beecham Group Plc Oxodiazole derivatives, processes for their production and pharmaceutical composition containing them
US4908456A (en) * 1989-04-05 1990-03-13 Takatori Corporation Process for preparing methylolated hydantoins
CN1084792C (zh) * 1999-05-31 2002-05-15 宝山钢铁股份有限公司 高风温高炉热风炉空气、煤气预热方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7706064A (nl) * 1976-06-03 1977-12-06 Wellcome Found Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten.
JPS5463083A (en) * 1977-09-05 1979-05-21 Wellcome Found Organism active nitrogen compound

Also Published As

Publication number Publication date
IT7949253A0 (it) 1979-05-30
ZA787354B (en) 1980-08-27
FR2427331A2 (fr) 1979-12-28
SE7904700L (sv) 1979-12-01
IT1164693B (it) 1987-04-15
AU4762579A (en) 1979-11-22
JPS554371A (en) 1980-01-12
BE876670R (fr) 1979-11-30
GB1599740A (en) 1981-10-07
FR2427331B2 (sv) 1983-01-28
NL7904311A (nl) 1979-12-04
DE2922070A1 (de) 1979-12-06

Similar Documents

Publication Publication Date Title
IL56556A (en) Pharmaceutical compositions comprising imidazole derivatives and certain such novel compounds
PH17460A (en) Hydantoin derivatives and pharmaceutical compositions containing the same
MY8600029A (en) 2-hydroxy-5-phenylazobenzoic acid derivatives and pharmaceutical compositions containing themn
IL57450A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing them
IL58579A0 (en) Nitrogen heterocyclic compounds their preparation and pharmaceutical compositions containing them
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
IL57849A (en) Imidazole derivatives and pharmaceutical compositions containing same
IL53094A0 (en) New hydantoin derivatives their preparation and pharmaceutical compositions containing them
IL58730A (en) Spiro-polycyclic imidazolidinedione derivatives and pharmaceutical compositions containing them
NZ184281A (en) Hydantoin derivatives and pharmaceutical compositions
IL57040A (en) Imidazole derivatives,their preparation and pharmaceutical compositions containing them
DE2862404D1 (en) Hydantoin derivatives, their preparation and pharmaceutical compositions containing them
IL57268A0 (en) Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them
IL60376A0 (en) 3-methyleneazetidine derivatives and pharmaceutical compositions containing them
IL58681A0 (en) Heterocyclic compounds their preparation and pharmaceutical compositions containing them
IL58620A0 (en) Aryltrifluoroethanol derivatives their preparation and pharmaceutical compositions containing them
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
NZ189896A (en) Phenylaniline derivatives and pharmaceutical compositions
NZ190245A (en) Isoquinoline derivatives and pharmaceutical compositions containing them
IL57436A0 (en) Hydantoin derivatives and pharmaceutical compositions containing them
IL60040A0 (en) Imidazole derivatives and pharmaceutical compositions containing them
IL57882A0 (en) 2-thiophenecarboxamido-alkylmercaptans and pharmaceutical compositions containing them
IL61038A0 (en) 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them
IL60695A0 (en) Hexahydro-trans-pyridoindole derivatives and pharmaceutical compositions containing them
NZ190665A (en) S-benzylcysteine derivatives and pharmaceutical compositions